Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
Drivers be aware of patchy fog, dense fog advisory in effect until 9 a.m.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
TenX Keane Acquisition - Ordinary Share
(NQ:
TENK
)
40.50
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Aug 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
40.50
Bid (Size)
37.26 (1)
Ask (Size)
39.86 (1)
Prev. Close
40.50
Today's Range
40.50 - 40.50
52wk Range
9.540 - 49.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bucking the Trend: 3 Stocks That Zoomed While the Market Crashed
August 14, 2024
Even as the market crashed last week there were some outperforming stocks that went on to double- and triple-digit gains.
Via
InvestorPlace
Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology
August 06, 2024
Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology
Via
News Direct
Performance
YTD
+269.86%
+269.86%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+261.61%
+261.61%
1 Year
+271.22%
+271.22%
More News
Read More
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
August 06, 2024
Via
Benzinga
S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge
August 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.